
Endoscopic remission is a recognized therapeutic endpoint in inflammatory bowel disease (IBD; Crohn’s disease (CD), ulcerative colitis (UC)). The impact of persistent histologic activity on long-term outcomes is less clear and limited by small studies.
Like
Save
Share